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Prognostic Inicators in Patients with Intracranial 
Tuberculoma: a review of 102 Cases 
M. Wasay,M. K.Moolani  ( Department of Medicine, The Aga Khan University,Karachi. )  
J.Zaheer,B.A. Kheleani,R. A. Smego,A. R. Sarwari  ( Department of Medicine, The Aga Khan 
University,Karachi. ) 
Abstract  
Objective: To see the characteristics, course and outcome of patients suffering from 
intracranial tuberculoma.  
Methods: Retrospective review of 102 patients diagnosed as intracranial tuberculoma at 
a tertiary care center over 10 years. 
Results: A total of 102 cases were seen with an age range of 1 to 75 years (mean, 30 
years). Predisposing factors included Diabetes mellitus (8 patients) and pregnancy or 
puerperium (7 patients). Five pediatric patients had tuberculoma despite documented 
BCG vaccination. Fever (59%), headache (57%), meningeal irritation (36%) were the 
commonest presenting features; one-third of patients were drowsy or comatosed at 
presentation. Cerebrospinal fluid analysis was performed in 63 patients, of whom 88% 
had elevated protein, 83% had low glucose, and 84% had pleocytosis (one-third with 
neutrophilia). Forty-nine (50%) patients had clinical or laboratory evidence of 
concomitant tuberculous meningitis, Chest radiographs showed active or old tuberculous 
infection (25%), with a miliary pattern in 20%. Two-thirds of subjects had multiple 
tuberculomas (mean, 4.5 lesions per patient) on contrast CT or MRI scan. Hydrocephalus 
was present in 37 (37%) patients of which 21 required shunt surgery. Thirty-nine patients 
had > 9 months of follow up; 17 patients showed complete recovery, 20 patients had 
partial recovery, and 2 patients had no response. Coma at presentation and miliary pattern 
on chest X-ray were predictors of poor prognosis. 
Conclusion: The study demonstrate that fever, headache, signs of meningeal irritation 
and cranial nerve palsies are common presenting features. Complete recovery was seen in 
40% patients. Coma and military TB are predictors of poor prognosis (JPMA 
54:83;2004). 
Introduction  
Although the lungs remain the major primary sites of Mycobacterium tuberculosis 
infection, many organs are potentially affected. Approximately 5-10% of cases of 
tuberculosis have central nervous system (CNS) involvement. 1 Intracranial tuberculosis 
has two related pathologic processes: tuberculous meningitis and intracranial 
tuberculoma. The two conditions are separate clinical entities, with only 10% of patients 
with tuberculoma having detectable meningeal involvement.1 Although tuberculomas are 
amongst the rarest intracranial space-occupying lesions in developed countries, they 
account for a significant proportion of intracranial mass lesions both in HIV -infected and 
uninfected individuals in tuberculosis endemic areas.2-4 Intracranial tuberculomas are 
histologically composed of granulomatous tissue and result from hematogenous spread 
from a distant focus of tuberculous infection. 1 Unlike malignant tumors of the central 
nervous system, tuberculomas often grow without permanently destroying the 
surrounding neural tissue, thus potentially enabling a good clinical recovery. However, 
tuberculomas may rupture into the subarachnoid space causing meningitis and affecting 
the brain parenchyma and cerebral blood vessels. 1 The purpose of this study was to 
determine the clinical, laboratory, radiographic, and treatment features and outcome in 
HIV -uninfected Pakistani patients with intracranial tuberculoma. 
Patients and Methods  
The medical records of 242 patients with a diagnosis of central nervous system 
tuberculosis seen at the Aga Khan University Hospital, between 1988-1999 were 
retrospectively reviewed. Patients were included in the study if one or more contrast-
enhancing lesions were identified on computed tomography (CT) scan or magnetic 
resonance imaging (MRI) of the brain (102 patients), and these space-occupying lesions 
were diagnosed as intracranial tuberculoma based on one or more of the following 
criteria: I) clinical and/or radiographic response to antituberculous chemotherapy (n = 
59); 2) microbiologic or histopathologic or radiographic evidence of active pulmonary or 
systemic tuberculosis (n = 24); 3) histopathologic features of granulomatous formation (n 
= 19) of the biopsied/excised CNS lesion. Variables studied included patient 
demographics, clinical features, laboratory investigations, radiologic findings, and 
outcome. Multiple logistic regression model was used to identify predictors of poor 
prognosis. The odds ratio and confidence interval were also calculated for each factor in 
relation to mortality. Data was statistically analyzed using an SPSS software program 
(version 8.0, copyright @ SPSS Inc; 1989-97). 
Results  
The study included 102 patients (male; 45, females; 57). The mean patient age was 30 
years, with a majority of patients between 15 and 45 years (range, I to 75 years). Only 6% 
patients were more than 60 years old, while 5% were below 5 years of age. Almost 70% 
patients had no prior history of tuberculosis or contact with a patient with tuberculosis. 
Predisposing factors for tuberculosis included diabetes mellitus (8 patients ), pregnancy 
or a puerperal state (7 patients), and the use of systemic corticosteroids or cytotoxic 
therapy (3 patients ). Five pediatric patients had intracranial tuberculoma despite 
documented Bacillus- Calmette-Guerin (BCG) vaccination as per World Health 
Organization guidelines. The median duration of symptomatology before diagnosis was 
20 days in children and 45 days in adults. Eight patients were comatosed. and 27 were 
drowsy at the time of presentation. Fever (59%) and headache (57%) were the most 
common presenting symptoms, while meningeal irritation (36%), cranial nerve palsies 
(33%; most commonly involving the facial or abducent nerves), and papilledema (19%) 
were the most common clinical signs. Peripheral leukocytosis was seen in one-half of the 
study cohort, while laboratory-documented anemia occurred in 30 (30%) patients. The 
erythrocyte sedimentation rate was recorded in only 60 patients and was found to be 
elevated in 41 (61%) subjects. Cerebrospinal fluid (CSF) analysis was performed in 63 
patients, and 49 (84%) had CSF pleocytosis (65% with mononuclear predominance and 
35% with neutrophilic predominance). Cerebrospinal fluid protein was elevated in 53 
(88%) and glucose was low in 48 (83%) patients. Cultures of CSF were positive for 
Mycobacterium tuberculosis in only 3 out of 63 patients. Clinical features and CSF 
parameters were suggestive of meningeal involvement (concomitant tuberculous 
meningitis) in 49 (49%) patients. Histopathologic evaluation was performed in 19 
patients. Specimens were obtained by either biopsy or surgical resection of intracranial 
tuberculoma, and the final diagnosis was based upon the presence of caseation necrosis 
with granulomata formation. Chest x-rays were performed in all subjects; active or healed 
tuberculosis was identified in 25 (25%) patients out of which, 20 (20%) patients had a 
miliary pattern. Computed tomography of the head was performed in 62 patients while 40 
patients underwent MRI scanning. More than two-thirds (69%) of patients had multiple 
tuberculomas, and the locations of lesions were supratentorial (56%), infratentorial 
(12%), or both (32%). The number of tuberculous lesions ranged from I to more than 
lOO (mean, 4.5 per patient), and occurred as follows: solitary lesion, 31 patients; 2-5 
lesions, 46 patients; > 6 lesions, 25 patients. The diameter of the largest [(0)] tuberculoma 
was 5 centimeters. Hydrocephalus was present in 37 (37%) patients and 21 required 
decompressive shunt surgery (Figures 1-5). [(1)] Eleven (11%) patients died. Fifty-one 
patients were lost to follow up after a variable period (2 weeks to 7 months). Long-term 
follow up of nine months or more was available for only 39 patients. All of these patients 
received isoniazid, rifampicin, and pyrazinamide. Patients also received ethambutol 
and/or streptomycin in all but two instances. Duration of treatment was 9-12 months in 
these 39 patients. Thirty one patients concomitantly received systemic corticosteroids. 
Twelve patients developed adverse drug effects, and antituberculous therapy was 
temporarily interrupted or discontinued in six patients, Seventeen patients had complete 
clinical and radiographic recovery, 20 patients had partial recovery (clinical and/or 
radiographic), and two patients had no clinical improvement. Most common neurologic 
sequelae were seizures (6 patients) and hemiplegia/monoplegia (5 patients). Follow up 
CT scans were available in seven patients. Follow up period ranged from one month to 
seven months. Three patients had complete resolution of tuberculoma while three patients 
showed a decrease in number and/or size of tuberculoma. One patient had no change in 
size of lesion. This lesion was subsequently excised and histopathology was consistent 
with tuberculoma. Follow-up MRI scans were available for only 13 patients; four of these 
had complete resolution of lesions after 6-12 months of therapy, while four patients had a 
decrease in the number and/or size of their tuberculoma(s) on repeat scan. Four patients 
had no change in the number and/or size of their space-occupying lesion 18 months after 
initiation of treatment. Two subjects had complete clinical recovery, one had partial 
recovery, and one had no clinical improvement. In one additional patient, the size of the 
tuberculoma increased after one year of treatment despite partial clinical recovery. Five 
of these 12 patients had no radiological improvement despite complete treatment. The 
diagnosis of tuberculoma in these patients was established on the basis of coexisting 
evidence of pulmonary tuberculosis. None of these patients underwent biopsy. A multiple 
regression analysis identified that coma at presentation (Odds ratio, 2.7, 95% confidence 
interval, 1.8 to 5.6) and military pattern on chest -x ray (Odds ratio, 3.0, 95% confidence 
interval, 1.6 to 6.6) were independent predictors of mortality ( P= 0.01). The size, 
location and number of tuberculoma (Odds ratio 1.2, Confidence interval 95%, 0.6-2.2, 
P=0.2), hydrocephalus (Odds ratio 1.3, 95 % confidence interval, 0.8-2.2, P=0.12) and 
concomitant tuberculous meningitis (Odds ratio 1.8, 95 % confidence interval, 0.8-2.6, 
P=0.08) were not found to be independent predictors. 
Discussion  
Intracranial tuberculosis is an important CNS infection in developing countries where 
tuberculosis is endemic. 1,5 In these regions, tuberculosis is the most common infectious 
cause of CNS space-occupying lesions in persons with and without HIV infection. 3 In 
Pakistan, HIV infection is rare and patients in our study cohort lacked historical and 
physical features suggestive of associated HIV / AIDS. As reported in the literature, most 
of our patients were late adolescents and young adults. 4 In view of its suppressive effects 
on cellular immunity, pregnancy is suggested to be a precipitating factor in at least 1% 
patients with CNS tuberculosis. 4 In our study, seven patients (8%) were either pregnant 
or in the puerperium, thus identifying these individuals as seriously at-risk for CNS 
tuberculoma. Fever was present more frequently (59%) in our patients than in previous 
series (10-25%). 4 This finding could reflect the higher incidence of concomitant 
tuberculous meningitis in our patients (50% ) than in previous reports. 1 As observed by 
others, papilledema and focal neurologic signs were more common in children, and signs 
of meningeal irritation were more common among adults. 4 Cranial nerve involvement 
was also seen more frequently in our study cohort than in other literature series, and is 
likely due to the increased incidence of meningeal involvement. 6 Cerebrospinal fluid 
evaluation is not always possible in patients with CNS tuberculoma because of the 
frequent increased intracranial pressure present which is a contraindication for lumbar 
puncture. Where spinal taps were performed, our patients exhibited typical CSF findings 
of mononuclear pleocytosis, elevated protein, and hypoglycorrachia, although 35%> of 
subjects had neutrophilic CSF pleocytosis. 7-9 As noted in other studies, 25% of our 
patients had evidence of pulmonary tuberculosis, either active or inactive, on chest x-ray. 
6 Magnetic resonance imaging is increasingly recognized as a better diagnostic modality 
for the diagnosis of tuberculoma, especially for brainstem tuberculoma. l0 In literature, 
15% to 40% patients are reported to have multiple tuberculomas 4,11 ; in our study, 69% 
cases had multiple CNS lesions. The mean number of lesions (4.5 per patient) in our 
study appears to differ notably from the number of lesions (2.1) seen in patients with 
concomitant HIV infection. 3 Locations of lesions were supratentorial (56%), 
infratentorial (12%), or both (32%); supratentorial lesions and brainstem tuberculoma ( 
198/0 ) were more common in our series than in previous reports. 4,12 In India and 
Africa, the incidence of brainstem tuberculoma varies from 2-8%. 4,5 These differences 
could be explained by the increased utility of MRI in the diagnosis of intracranial mass 
lesions in our study cohort (more than one-third of our patients underwent MRI) 
compared to studies in the pre- or early-MRI era. 4,5 Previous studies have suggested that 
most patients with intracranial tuberculoma can be treated successfully with 
antituberculous therapy without surgical intervention.11,13,14 Isoniazid and 
pyrizinamide have better CSF penetration compared to rifampicin, streptomycin, and 
ethambutol. 15,16 Empiric antituberculous therapy, pending drug susceptibility results, 
should take into account local resistance patterns and typically includes four-drugs, 
isoniazid, pyrizinamide and rifampicin plus streptomycin or ethambutol. Such regimens 
are also effective for patients with concomitant tuberculous meningitis.6 The 
recommended duration of antituberculous therapy for intracranial tuberculoma is 9 to 18 
months. 17,18 As for patients with meningeal involvement, the judicious use of 
corticosteroids is indicated for selected patients with CNS tuberculoma including those 
with clinical signs or symptoms of mass effect and increased intracranial pressure, and 
patients with large lesions. 19,20 More than one-quarter of our patients received 
adjunctive corticosteroids. The prognosis of intracranial tuberculoma cannot be reliably 
predicted from our study due to the unavailability of long-term follow up in a majority of 
subjects. Mortality was at least 11% and may have been higher because long- term 
outcomes were available in only 39 patients. Of these, 17 (41 %) patients had complete 
recovery. The radiographic outcome of patients with intracranial tuberculomas is variable 
and does not always appear to correlate with length of treatment or clinical recovery. 
Tuberculomas may resolve, decrease or increase in number and size, or remain 
unchanged after completion of therapy. 21 Complete clinical recovery was seen in some 
patients despite persistence of lesions, while some patients had no recovery despite 
complete resolution of tuberculomas. 
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